Post-activation Performance Enhancement in Soccer Players:
Launched by KARABUK UNIVERSITY · Mar 8, 2025
Trial Information
Current as of April 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific type of warm-up routine, called Post-Activation Potentiation (PAPE), can help improve the performance of male soccer players. The goal is to see if this warm-up method can enhance their ability to change directions quickly during a game. Soccer players will take part in two testing sessions that are 48 hours apart. During these sessions, they will first complete a pre-test, then perform the PAPE warm-up, and finally do a series of direction change tests at different times to measure their performance.
To be eligible for this trial, participants must be healthy male soccer players aged between 65 and 75 years. They should be willing to stick to the planned sessions throughout the study. However, those under 18 years old or with chronic health issues that might affect their ability to exercise won’t be able to participate. This trial is currently active, but it is not recruiting new participants at this time.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Being healthy
- • Male soccer players
- • Willing to maintain the intervention for all sessions
- Exclusion Criteria:
- • Under 18 years of age
- • Having a chronic disease
- • Contraindications for exercise
About Karabuk University
Karabuk University is a distinguished educational institution located in Turkey, dedicated to advancing scientific research and innovation across various fields, including healthcare. As a clinical trial sponsor, the university plays a pivotal role in facilitating cutting-edge research aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodology, Karabuk University collaborates with healthcare professionals and researchers to design and implement clinical trials that address pressing health challenges, ultimately striving to enhance treatment options and promote public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karabük, , Turkey
Patients applied
Trial Officials
Neslihan Akçay
Study Chair
Karabuk University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported